Merck Gives Earnings Update Oct. 21, Pfizer Oct. 20
This article was originally published in The Pink Sheet Daily
Executive Summary
Impact of Merck’s Vioxx withdrawal is likely to surface during both companies’ presentations; Merck will present data on Vioxx 25 mg at a rheumatology conference earlier in the week.